Cloud-first automation is the future ??
Well, hello there!
Welcome to the July edition of Automata's newsletter ??
This month, we're exploring some of the many benefits of lab automation, from scaling throughput to increased sustainability. In our recent panel discussion, 'Advances in Bio-Automation,' industry experts share their automation experience and how it has improved their companies' processes.?
Continue reading for the challenges facing cancer genome sequencing, how to overcome them, and why cloud-first automation is the future.
Enjoy!
Team Automata ??
Advances in bio-automation
We have divided the recording of our recent Advances in Bio-Automation event into nine shorter clips, each focusing on different topics covered by the panellists.
To get started, choose the title that intrigues you most...
You can also watch the full panel discussion via the link below ??
Automation in cancer genome sequencing
Genome sequencing has ushered in a wealth of opportunities for clinicians to refine cancer diagnosis and tailor treatments specifically to individual patients. The introduction of lab automation could further advance cancer genomics sequencing by bolstering data quality and accessibility, eradicating bottlenecks, and aiding scalability.
Our article explores the challenges facing cancer genome sequencing and how to overcome them.
The benefits of cloud-first automation
In the rapidly evolving landscape of laboratory automation, labs have traditionally relied on on-premises solutions. However, the rise of secure and flexible cloud-first automation is ushering in a new era of highly responsive platforms that harness the transformative power of data and enable collaboration beyond physical and geographical boundaries.?
In his?article—linked below— Daniel S. explores cloud-first automation, why it’s the future for innovative laboratories and the benefits it can bring compared to non-cloud solutions.
Sustainability in lab automation
Our Strategic Partnerships Lead, Emma Norris , discusses sustainability in laboratory automation during a recent panel held by eLabNext .
Discover how innovative technologies such as automation, data management, and eco-friendly materials can revolutionise research workflows in labs. Industry experts share practical tips and real-world case studies on enhancing efficiency, reducing waste, and minimising environmental impact.
?? WATCH NOW
Common manual ELISA errors
Enzyme-linked immunosorbent assay (ELISA) is a fundamental technique in immunology, commonly used to quantify antibodies, antigens, proteins, and glycoproteins in biological samples.
While manual execution of ELISA is still common in many research and diagnostic labs, it is prone to human error, leading to inconsistent results.
Our blog post shares frequent mistakes made during manual ELISA and highlights how automation can mitigate these issues.
The journey to full automation
The laboratory of the future will be automated – there’s no question about that.
Whether focused on research and development (R&D), bioprocessing, testing, analytics, or research, our best scientists will be empowered to use their full creative and analytical capabilities to solve some of the biggest challenges in life sciences.
However, too many talented minds are occupied with menial, manual, mind-numbing tasks. Our Director of Product, Russell Green , outlines the steps that labs must take towards full automation in his article for Innovations in Pharmaceutical Technology (IPT) 's Summer Edition.
Book a LINQ demo
Come and visit our brand-new demo space in London to meet Automata LINQ, the complete lab workflow automation solution. A smart bench with integrated instruments and scheduling software capabilities.
The demo workcell is multi-assay capable and includes cell-based assays, cell maintenance, ELISA and genomics pre-PCR.
?? BOOK NOW
Let's stay in touch ??
By subscribing to our newsletter, you'll get a copy of each newsletter delivered straight to your email inbox without having to lift a finger. Automation at its finest...
?? SUBSCRIBE HERE ??